Pharmaron Beijing Co Ltd
SZSE:300759
Pharmaron Beijing Co Ltd
Net Income (Common)
Pharmaron Beijing Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Net Income (Common)
¥1.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Net Income (Common)
¥9.6B
|
CAGR 3-Years
48%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Net Income (Common)
¥3.4B
|
CAGR 3-Years
26%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Net Income (Common)
¥2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
34%
|
CAGR 10-Years
36%
|
|
Genscript Biotech Corp
HKEX:1548
|
Net Income (Common)
-$95.5m
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
Net Income (Common)
¥155.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Pharmaron Beijing Co Ltd's Net Income (Common)?
Net Income (Common)
1.6B
CNY
Based on the financial report for Dec 31, 2023, Pharmaron Beijing Co Ltd's Net Income (Common) amounts to 1.6B CNY.
What is Pharmaron Beijing Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
37%
Over the last year, the Net Income (Common) growth was 16%. The average annual Net Income (Common) growth rates for Pharmaron Beijing Co Ltd have been 11% over the past three years , 37% over the past five years .